A pharmaceutical company in Guizhou Province received a special fund of 1.3 million yuan

Pharmaceutical Network Enterprise News: Guizhou Province's top ten hundred billion industrial industries are the province's industrial system, the "four pillars and eight pillars", accounting for more than 95% of the province's industrial economic structure, the total output value of more than 1.2 trillion yuan in 2019, driving the province's industrial value-added above the scale of 9.6%
In 2018, Guizhou Province issued the "Ten Billion-level Industrial Revitalization Action Plan of Guizhou Province", the program clearly, by 2020, the province's total industrial output value reached 1.8 trillion yuan, the initial formation of Guizhou's characteristics of the modern industrial system;
In addition, in order to help the province's health and pharmaceutical industry to achieve high-quality development, on October 1, 2019, Guizhou Provincial Office of Industry and Information Technology issued the "Top 10 000 billion industrial (health and pharmaceutical) industry revitalization of the special fund declaration guide." In terms of the scope of the declaration, the pharmaceutical manufacturing industry mainly supports pharmaceutical reform and expansion projects, pharmaceutical policy awards, technological innovation projects, energy conservation and comprehensive utilization of resources projects, pharmaceutical manufacturing park projects, market development, brand building, publicity and training, consulting services
At present, there have been declared Guizhou pharmaceutical enterprises received "The top ten hundred billion industrial (health medicine) industry revitalization" special funds
On March 18, Jingfeng Pharmaceutical Subsidiary Guizhou Jingcheng Pharmaceutical Co., Ltdannounced that the company has obtained the Guizhou Provincial Finance Department, the provincial Department of Industry and Information Technology issued the "Guizhou Province 10 billion industrial (health medicine) industry revitalization" special funds 1.3 million yuan, to further build Guizhou Jingcheng Pharmaceutical "provincial enterprise technology center" of science and technology, talent, intellectual resources advantages, and the company's advantages of resources to form an integrated complement
Jingfeng Pharmaceutical said that in accordance with the "Guizhou Province 100 billion industrial (health medicine) industry revitalization program", Guizhou Jingcheng Pharmaceutical will give full play to Guizhou Province's natural ecological resources and traditional Chinese medicine, ethnic medicine advantages, highlighting the pharmaceutical manufacturing in the health industry in the important cornerstone role, stimulate innovative vitality, and constantly meet the multi-level, diversified people's health needs, help "healthy China" construction
Data show that Jingfeng Pharmaceutical was founded in 1993, early 2013 by the listed enterprise Jingfeng Pharmaceutical Holdings, became a member of a large pharmaceutical company, Jingfeng Chinese medicine preparation platform headquartersThe company's production base is located in Guiyang City Shuwen County Zazo Pharmaceutical Park, the scope of business and GMP production line has capsules, aerosols, granules, antidotes, Chinese medicine tablets (including Chinese medicine extraction), is a collection of pharmaceutical development, production, sales as one of the high-tech pharmaceutical enterprises
The company mainly produces and sells products including cardioenin capsules, anti-inflammatory biliary capsules, women's flat capsules, Tongdi capsules, children's spring particles, ice cream aerosols, compound lyasol aerosols, analgesics, Chinese medicine (broken walls) drink tablets, Guizhou Sanbao and other productsIts central encephalincapsules and anti-inflammatory biliary capsules for the national health insurance catalog varieties, anti-inflammatory biliary capsules for the national base medicine, cardio-encephalinin capsules and women's capsules have entered the 2015 edition of the "Chinese Pharmacopoeia" and supplementary edition
In recent years, Guizhou Jingcheng Pharmaceuticals by virtue of "Kingfeng Pharmaceutical" strong economic strength and management experience, rapid development and upgradingFinancial data show that in 2016, the company's sales revenue of 289 million yuan, profit 40.52 million yuan, tax 39.2 million yuan; At present, Jingcheng Pharmaceutical has been the province's innovative enterprises, provincial brand-name products, provincial technology centers, provincial private enterprises 100 and other honors.